Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Blonanserin (AD-5423) is an atypical antipsychotic approved in Japan in January, 2008. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms, excessive sedation, or hypotension.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 7,500 | |||
10 mg | 在庫あり | ¥ 11,000 | |||
25 mg | 在庫あり | ¥ 19,500 | |||
50 mg | 在庫あり | ¥ 29,000 | |||
100 mg | 在庫あり | ¥ 40,500 | |||
200 mg | 在庫あり | ¥ 72,500 |
説明 | Blonanserin (AD-5423) is an atypical antipsychotic approved in Japan in January, 2008. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms, excessive sedation, or hypotension. |
ターゲット&IC50 | 5-HT2:3.98 nM(Ki), D2 receptor:14.8 nM(Ki) |
別名 | AD-5423 |
分子量 | 367.5 |
分子式 | C23H30FN3 |
CAS No. | 132810-10-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 14.29 mg/mL (38.88 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Blonanserin 132810-10-7 GPCR/G Protein Neuroscience Sigma receptor 5-HT Receptor Adrenergic Receptor Dopamine Receptor schizophrenia 5-hydroxytryptamine Receptor antipsychotic AD 5423 excessive sedation Inhibitor Sigma Receptor AD5423 AD-5423 social deficit extrapyramidal symptom hypotension Beta Receptor inhibit Serotonin Receptor inhibitor